“How can patients and the legislature steer the biopharmaceutical industry towards sustainable innovation?”

“At Catenion, I can put my scientific background in cell therapy and regenerative medicine to practical use and help bring innovative therapies to the market.”

Dr. Pascal Joly Manager

“I help R&D teams deliver on the promise of gene therapy.”

“Change-Management is a team effort – let’s get started.”

Dr. Matthias Krings Senior Partner

“Enhance decision making through a data-driven approach: challenging assumptions and exploring new ideas – this is our passion.”

“We develop strategies that empower our clients to drive innovation and bring new treatments from promises to patients.”

“Is biopharma ready to embrace the new biology?”

Dr. Markus Thunecke Senior Partner

“Using my scientific expertise to identify game-changing technology and solve strategic R&D challenges combines my passion with real outcomes.”

“Increasingly, bioconvergent therapeutics and hybrid products and services promise cures; with current pharmaco-economic pricing rationales, these will be cost-effective but they will bankrupt the system.”

Christian Elze Senior Partner

“Helping clients around the globe to unleash the power of immune system in the fight against a plethora of diseases is a very rewarding career path for a trained immunologist.”


In Vivo Biopharma RD Productivity-Growth 2018

In 2017, R&D productivity of the top-30 pharmaceutical companies had decreased for the first time since 2014, according to ….

Financier – M&A in biopharma – why bigger is not better

Numerous studies by academics and consultants demonstrate that M&A, on average, destroys value. A recent study performed on the Russe II 3000 index from 2001 to 2013 shows that most M&A is dilutive to earnings growth over an extended period post-merger. …
Download this article

Meet Us

November 27th, 2019

Risky Business Workshop – Newcastle University

September 24th, 2019

Life Sciences + Euron PhD Days 2019 – University of Luxembourg

September 13th, 2019

Harvard’s Consulting Networking Night – Boston

March 1st, 2019

“Maximizing Value from Strategic Partnering in Clinical Development” Greenberg Traurig – Tokyo

March 2nd, 2019

New York Academy of Sciences – The Future of Biopharmaceutical Innovation – New York